Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)

SHA:600572 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	904.56	1,674	1,322	2,570	2,468	2,573
Cash & Short-Term Investments	904.56	1,674	1,322	2,570	2,468	2,573
Cash Growth	3.63%	26.60%	-48.56%	4.13%	-4.09%	63.19%
Accounts Receivable	1,968	1,520	1,665	1,756	1,638	1,671
Other Receivables	74.64	62.47	87.74	38.22	59.41	84.42
Receivables	2,849	1,582	1,753	1,794	1,697	1,755
Inventory	1,104	1,230	1,266	1,333	1,128	1,044
Prepaid Expenses	-	0.03	0.26	0.61	0.89	1.02
Other Current Assets	77.16	71.95	78.18	77.26	101.74	92.17
Total Current Assets	4,935	4,558	4,419	5,775	5,395	5,466
Property, Plant & Equipment	2,736	2,872	3,047	3,048	3,220	3,251
Long-Term Investments	1,838	1,897	1,774	1,723	1,629	1,881
Goodwill	184.72	184.72	184.72	184.72	184.72	184.72
Other Intangible Assets	358.76	371.95	349.19	355.45	390.79	362.43
Long-Term Deferred Tax Assets	60.08	38.83	41.16	78.94	55.46	27.5
Long-Term Deferred Charges	17.89	22.59	67.46	46.35	40.66	66.81
Other Long-Term Assets	36.49	39.37	19.31	25.86	14.82	34.78
Total Assets	10,167	9,984	9,902	11,238	10,931	11,274

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	847.63	848.28	868.76	819.53	629.13	540.19
Accrued Expenses	311.51	970.32	963.41	1,205	1,005	873.5
Short-Term Debt	21.01	157.42	210.56	849.71	717.73	1,344
Current Portion of Long-Term Debt	66.98	100.03	91.07	77.79	138.63	129.65
Current Portion of Leases	4.59	5.27	2.23	4.4	6.15	4.63
Current Income Taxes Payable	48.05	48.59	44.84	56.45	51.38	28.5
Current Unearned Revenue	37.49	37.2	37.68	43.65	113.3	36.68
Other Current Liabilities	1,282	271.29	297.88	115.87	128.07	210.8
Total Current Liabilities	2,619	2,438	2,516	3,173	2,789	3,168
Long-Term Debt	20.01	40	117.87	305.03	330.3	9.5
Long-Term Leases	0.85	0.99	2.05	0.72	3.97	4
Long-Term Unearned Revenue	106.88	109.88	116.21	141.11	154.22	146.83
Long-Term Deferred Tax Liabilities	238.15	241.95	235.6	268.27	328.79	310.3
Other Long-Term Liabilities	0.97	0.96	0.94	0.93	0.92	0.92
Total Liabilities	2,986	2,832	2,989	3,889	3,607	3,639

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2,539	2,535	2,583	2,570	2,570	2,570
Additional Paid-In Capital	299.83	284.02	285.66	210.32	149.54	359.76
Retained Earnings	4,165	4,168	4,251	4,261	4,194	4,271
Treasury Stock	-	-	-299.99	-	-	-
Comprehensive Income & Other	62.17	60.15	-0.11	-0.01	0.1	0.27
Total Common Equity	7,066	7,047	6,820	7,041	6,914	7,201
Minority Interest	115.18	105.11	92.97	308.58	410.18	434.01
Shareholders' Equity	7,181	7,152	6,913	7,350	7,324	7,635
Total Liabilities & Equity	10,167	9,984	9,902	11,238	10,931	11,274

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	113.45	303.7	423.77	1,238	1,197	1,492
Net Cash (Debt)	791.11	1,370	898.34	1,332	1,271	1,082
Net Cash Growth	38.66%	52.51%	-32.57%	4.81%	17.53%	-
Net Cash Per Share	0.32	0.55	0.36	0.52	0.50	0.42
Filing Date Shares Outstanding	2,539	2,535	2,519	2,570	2,570	2,570
Total Common Shares Outstanding	2,539	2,535	2,519	2,570	2,570	2,570
Working Capital	2,316	2,120	1,902	2,603	2,606	2,298
Book Value Per Share	2.78	2.78	2.71	2.74	2.69	2.80
Tangible Book Value	6,522	6,490	6,286	6,501	6,338	6,654
Tangible Book Value Per Share	2.57	2.56	2.49	2.53	2.47	2.59
Buildings	2,403	2,403	2,427	2,250	2,138	2,055
Machinery	2,969	2,924	2,765	2,655	2,279	1,888
Construction In Progress	37.8	72.77	139.45	238.37	661.93	1,068

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error